(S (NP (NNP Breast) (NN cancer)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ main) (NNS causes)) (PP (IN of) (NP (NN death))) (ADVP (NN worldwide)))))) (. .))
(S (NP (NP (JJ Histopathological) (NN cellularity) (NN assessment)) (PP (IN of) (NP (NP (JJ residual) (NNS tumors)) (PP (IN in) (NP (JJ post-surgical) (NNS tissues)))))) (VP (VBZ is) (VP (VBN used) (S (VP (TO to) (VP (VB analyze) (NP (NP (NP (DT a) (NN tumor) (POS 's)) (NN response)) (PP (TO to) (NP (DT a) (NN therapy))))))))) (. .))
(S (NP (NNP Correct) (NN cellularity) (NN assessment)) (VP (VP (VBZ increases) (NP (NP (DT the) (NNS chances)) (PP (IN of) (S (VP (VBG getting) (NP (DT an) (JJ appropriate) (NN treatment))))))) (CC and) (VP (VBZ facilitates) (NP (NP (DT the) (NN patient) (POS 's)) (NN survival)))) (. .))
(S (S (PP (IN In) (NP (JJ current) (JJ clinical) (NN practice))) (, ,) (NP (NN tumor) (NN cellularity)) (VP (VBZ is) (VP (ADVP (RB manually)) (VBN estimated) (PP (IN by) (NP (NNS pathologists)))))) (: ;) (S (NP (DT this) (NN process)) (VP (VBZ is) (ADJP (ADJP (JJ tedious)) (CC and) (ADJP (NN prone) (PP (TO to) (NP (NP (NNS errors)) (CC or) (NP (NP (JJ low) (NN agreement) (NNS rates)) (PP (IN between) (NP (NNS assessors)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (, ,) (NP (PRP we)) (VP (VBD evaluated) (NP (NP (CD three) (JJ strong) (JJ novel) (NNP Deep) (JJ Learning-based) (NNS approaches)) (PP (IN for) (NP (NP (JJ automatic) (NN assessment)) (PP (IN of) (NP (NN tumor) (NN cellularity))) (PP (IN from) (NP (NP (JJ post-treated) (NN breast) (JJ surgical) (NNS specimens)) (VP (VBN stained) (PP (IN with) (NP (NN hematoxylin) (CC and) (NN eosin)))))))))) (. .))
(S (NP (PRP We)) (VP (VBD validated) (NP (DT the) (VBN proposed) (NNS methods)) (PP (IN on) (NP (NP (DT the) (NNP BreastPathQ) (NNP SPIE) (NN challenge) (NN dataset)) (SBAR (WHNP (WDT that)) (S (VP (VBD consisted) (PP (IN of) (NP (NP (CD 2395) (NN image) (NNS patches)) (VP (VBN selected) (PP (IN from) (NP (NP (JJ whole) (NN slide) (NNS images)) (VP (VBD acquired) (PP (IN from) (NP (CD 64) (NNS patients))))))))))))))) (. .))
(S (PP (VBN Compared) (PP (TO to) (NP (VB expert) (JJ pathologist) (NN scoring)))) (, ,) (NP (PRP$ our) (ADJP (JJS best) (VBG performing)) (NN method)) (VP (VBD yielded) (NP (NP (NP (NP (DT the) (NNP Cohen) (POS 's)) (JJ kappa) (NN coefficient)) (PP (IN of) (NP (NP (CD 0.70)) (PRN (-LRB- -LRB-) (PP (FW vs.) (NP (NP (CD 0.42)) (VP (ADVP (RB previously)) (VBN known) (PP (IN in) (NP (NN literature)))))) (-RRB- -RRB-))))) (CC and) (NP (NP (DT the) (JJ intra-class) (NN correlation) (NN coefficient)) (PP (IN of) (NP (NP (CD 0.89)) (PRN (-LRB- -LRB-) (PP (FW vs.) (NP (CD 0.83))) (-RRB- -RRB-))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (ADJP (NNP Deep) (JJ Learning-based)) (NNS methods)) (VP (VBP have) (NP (DT a) (JJ significant) (NN potential) (S (VP (TO to) (VP (VP (VB alleviate) (NP (NP (DT the) (NN burden)) (PP (IN on) (NP (NNS pathologists))))) (, ,) (VP (VB enhance) (NP (DT the) (JJ diagnostic) (NN workflow))) (, ,) (CC and) (, ,) (VP (ADVP (RB thereby)) (, ,) (VB facilitate) (NP (NP (JJR better) (JJ clinical) (NNS outcomes)) (PP (IN in) (NP (NN breast) (NN cancer) (NN treatment))))))))))))) (. .))
